Early oral anticoagulation is non-inferior to delayed treatment in patients with ischemic stroke and atrial fibrillation
1. Early DOAC therapy within 4 days was non-inferior to delayed therapy for the composite outcome of recurrent ischemic or ...
Tag: direct oral anticoagulant (DOAC)
#VisualAbstract: Early Timing of Anticoagulation after Acute Ischemic Stroke with Atrial Fibrillation was Noninferior to Delayed Timing
Click here to read this study in the Lancet. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be ...
Depression may be associated with reduced adherence to direct-acting oral anticoagulants in atrial fibrillation patients
1. In this cross-sectional study, the odds of adequate or optimal adherence to direct-acting oral anticoagulants were lower in atrial ...
Wellness Check: Mental Health
Internet gaming disorders may be associated with insomnia, paranoid ideation, and psychoticism 1. In this cross-sectional study, a higher internet ...
Indefinite anticoagulation for unprovoked venous thromboembolism is not cost-effective
1. In this Markov modeling study, indefinite anticoagulation for first unprovoked venous thromboembolism (VTE) cost $16,014 more per person than ...
Apixaban is associated with a lower risk of gastrointestinal bleeding than other direct oral anticoagulants
1. In this population-based cohort study, apixaban was associated with a lower risk of gastrointestinal bleeding (GIB) as compared to ...
Asundexian does not reduce the risk of recurrent strokes after non-cardioembolic ischemic stroke
1. The composite of MRI-detected brain infarcts and symptomatic ischemic stroke was comparable across different doses of asundexian and placebo. ...
Left atrial appendage occlusion is an effective alternative to oral anticoagulation in atrial fibrillation
1. The overall benefit of left atrial appendage occlusion (LAOO) for prevention of stroke in patients with atrial fibrillation (AF) ...
#VisualAbstract: Concurrent use of tamoxifen with direct oral anticoagulants is not associated with an increased risk of hemorrhage
Click to read this study in JAMA Network Open.
Reduced bleeding risk with asundexian compared to apixaban in patients with atrial fibrillation
1. Asundexian 50 mg resulted in a lower rate of bleeding compared to apixaban 5 mg twice daily. 2. The ...